Showing results (161-170 of 582) with videos related to
Sort By:
Pageof 59
Experimental and Clinical Psychopharmacology|December 18, 2008
Dual dopamine/serotonin releasers: potential treatment agents for stimulant addictionRichard B Rothman, Bruce E Blough, Michael H BaumannThe AAPS Journal|April 6, 2007
Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictionsRichard B Rothman, Bruce E Blough, Michael H BaumannDrug and Alcohol Dependence|July 13, 2000
Comparative neurobiological effects of ibogaine and MK-801 in ratsM H Baumann, R B Rothman, S F AliTrends in Pharmacological Sciences|November 21, 2018
Pharmacological Research as a Key Component in Mitigating the Opioid Overdose CrisisMichael H Baumann, Theresa A Kopajtic, Bertha K MadrasAnnals of the New York Academy of Sciences|July 10, 2002
Appetite suppressants as agonist substitution therapies for stimulant dependenceRichard B Rothman, Bruce E Blough, Michael H BaumannJournal of Immunology (Baltimore, Md. : 1950)|December 15, 1993
Divergent transforming growth factor-beta effects on IL-6 regulation of acute phase plasma proteins in rat hepatoma cellsS P Campos, Y Wang, A Koj, et al.Trends in Pharmacological Sciences|October 24, 2006
Dual dopamine-5-HT releasers: potential treatment agents for cocaine addictionRichard B Rothman, Bruce E Blough, Michael H BaumannAnnals of the New York Academy of Sciences|November 2, 2017
Neurochemical and Neuroendocrine Effects of Ibogaine in Rats: Comparison to MK-801Michael H Baumann, Richard B Rothman, Syed F AliNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 21, 2021
Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in miceGrant C Glatfelter, John S Partilla, Michael H BaumannAnnals of the New York Academy of Sciences|July 21, 1998
Neurochemical and neuroendocrine effects of ibogaine in rats: comparison to MK-801M H Baumann, R B Rothman, S F AliPageof 59